Correlation Between Aquestive Therapeutics and Corpay
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Corpay at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Corpay into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Corpay Inc, you can compare the effects of market volatilities on Aquestive Therapeutics and Corpay and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Corpay. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Corpay.
Diversification Opportunities for Aquestive Therapeutics and Corpay
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Aquestive and Corpay is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Corpay Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corpay Inc and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Corpay. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corpay Inc has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Corpay go up and down completely randomly.
Pair Corralation between Aquestive Therapeutics and Corpay
Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 3.08 times more return on investment than Corpay. However, Aquestive Therapeutics is 3.08 times more volatile than Corpay Inc. It trades about 0.08 of its potential returns per unit of risk. Corpay Inc is currently generating about 0.09 per unit of risk. If you would invest 91.00 in Aquestive Therapeutics on September 12, 2024 and sell it today you would earn a total of 291.00 from holding Aquestive Therapeutics or generate 319.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aquestive Therapeutics vs. Corpay Inc
Performance |
| Timeline |
| Aquestive Therapeutics |
| Corpay Inc |
Aquestive Therapeutics and Corpay Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aquestive Therapeutics and Corpay
The main advantage of trading using opposite Aquestive Therapeutics and Corpay positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Corpay can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corpay will offset losses from the drop in Corpay's long position.| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Lantheus Holdings | Aquestive Therapeutics vs. ANI Pharmaceuticals | Aquestive Therapeutics vs. Ironwood Pharmaceuticals |
| Corpay vs. Aquestive Therapeutics | Corpay vs. Hawkins | Corpay vs. Avient Corp | Corpay vs. Merit Medical Systems |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |